NCT Number: NCT01745393
Kids Safe and Smokefree (KiSS)
The study's primary aim is to test the hypothesis that an intervention integrating pediatric clinic-level quality improvement with home-level behavioral counseling (CQI+BC) will result in greater reductions in child cotinine (a biomarker of secondhand smoke exposure) and reported cigarettes exposed/day than a clinic-level quality improvement plus attention control intervention (CQI+A). A secondary aim is to test the hypothesis that relative to CQI+A, CQI+BC will result in higher cotinine-verified, 7-day point prevalence quit rate among parents.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Children's Hospital of Philadephia, Philadelphia, Pennsylvania, United States
About this study
Child secondhand smoke exposure (SHSe) is a significant public health problem that has been linked to asthma, acute respiratory illnesses, otitis, and SIDS, and is associated with increased risk of cancers, cardiovascular disease, and behavior problems. This project will test the effectiveness of a comprehensive multilevel intervention to reduce young children's SHSe in minority and medically underserved communities known to have the highest SHSe-related morbidity and mortality risk. First, we will provide a clinic-level quality improvement (CQI) intervention to improve the care of pediatric patients with SHSe in four pediatric clinics in North and West Philadelphia. We will then randomize eligible parents visiting the CQI clinics into either a home-level behavioral counseling intervention (CQI+BC) or a home-level attention control intervention (CQI+A). In addition to clinic-level intervention, CQI+BC provides personalized, behavioral counseling with intensive skills training and support where SHSe occurs (in the home), as well as systems navigation to facilitate access to and effective use of reimbursable nicotine replacement therapy and smoking cessation medication. Participants will complete assessments at pre-treatment, 3-month end of treatment, and 12-month follow-up.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- at least 18 years of age
- English-speaking
- parent or legal guardian of child under 11 years old who lives with him/her
- daily smoker
Exclusion criteria
- non-nicotine drug dependence
- psychiatric disturbance (bipolar, schizophrenia, psychosis)
- pregnant
- inadequate health literacy
Treatment and study plan
Clinic Quality Improvement + Attention Control
BehavioralPrimary outcomes
-
Child Urine Cotinine
Time frame: up to 12 months
Child urine cotinine is a biomarker for assessing second-hand smoke exposure. We anticipate the CQI+BC treatment group will experience a greater reduction in child urine cotinine over time than the CQI+A control group.
-
Parent-reported Second-hand Smoke Exposure in Cigarettes Per Day From All Sources
Time frame: up to 12 months
Parental report of cigarettes child is exposed to each day in the home and car by all sources during the 7 days prior to assessment. We anticipate the CQI+BC treatment group will report greater reductions in second-hand smoke exposure over time than the CQI+A control group.
Secondary outcomes
-
Parent-reported Cotinine-verified 7-day Point Prevalence Abstinence
Time frame: up to 12 months
When a participant reports smoking abstinence, we will bioverify their smoking status.
Sponsors and collaborators
Lead sponsor
Temple University
Other
Collaborators
- Children's Hospital of Philadelphia
- St. Christopher's Hospital for Children
Registry information
Official study title
Pediatrician Advice, Family Counseling & SHS Reduction for Underserved Children
Acronym: KiSS
Important dates
- Study start
- 2012
- Primary completion
- 2016
- Study completion
- 2016
- First posted
- Dec 10, 2012
- Registry last updated
- Aug 8, 2018
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Babies Living Safe and Smokefree
NCT02602288
Chemically-Induced Disorders, Mental Disorders
Philadelphia, Pennsylvania, United States
View Trial DetailsSmoke-free Home Intervention in Permanent Supportive Housing
NCT04855357
Behavior, Health Behavior
San Francisco, California, United States
View Trial DetailseCEASE to Support Treatment for Parental Tobacco Use
NCT04974736
Behavior, Health Behavior
Philadelphia, Pennsylvania, United States
View Trial DetailsA Brief Digital Screening Tool to Address Tobacco and E-cigarette Use in Pediatric Medical Care
NCT05366790
Behavior, Health Behavior
Montreal, Quebec, Canada
View Trial Details